Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Embracing Future HoldingsSGX:8YY -7.14% FCF Yield % is -2.85 as of Jul. 25, 2026. The stock has 5 warning signs investors should review. Among 214 Medical Diagnostics & Research companies, Embracing Future Holdings ranks worse than 55.14% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
The historical rank and industry rank for Embracing Future Holdings's FCF Yield % or its related term are showing as below:
SGX:8YY'
s FCF Yield % Range Over the Past 10 Years
Min: -63.7 Med: -22.6 Max: -1.28
Current: -2.85
During the past 11 years, the highest FCF Yield % of Embracing Future Holdings was -1.28%. The lowest was -63.70%. And the median was -22.60%.
SGX:8YY's FCF Yield % is ranked worse than 55.14% of 214
companies
in the Medical Diagnostics & Research industry
Industry Median: -1.355
vs SGX:8YY: -2.85
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Embracing Future Holdings FCF Yield % Related Terms
Embracing Future Holdings FCF Yield % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, Embracing Future Holdings's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Embracing Future Holdings FCF Yield % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Embracing Future Holdings's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Embracing Future Holdings's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Embracing Future Holdings (SGX:8YY) has a FCF Yield % of -2.85 as of Jul. 25, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Embracing Future Holdings and its competitors. According to the industry distribution chart, Embracing Future Holdings ranks #118 out of 214 companies in the Medical Diagnostics & Research industry, placing it in the top 55.1%.
Is Embracing Future Holdings' FCF Yield % too high?
Embracing Future Holdings' current FCF Yield % is -2.85. Based on the distribution chart, Embracing Future Holdings ranks #118 out of 214 companies in the Medical Diagnostics & Research industry, which is below the industry midpoint.
How does Embracing Future Holdings' FCF Yield % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Embracing Future Holdings ranks #118 out of 214 companies for FCF Yield %. This places Embracing Future Holdings in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Medical Diagnostics & Research company?
A good FCF Yield % depends on the Medical Diagnostics & Research industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Embracing Future Holdings and its competitors. Embracing Future Holdings's current FCF Yield % is -2.85. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Embracing Future Holdings stock overvalued right now?
Embracing Future Holdings (SGX:8YY) has a current FCF Yield % of -2.85. The current FCF Yield % is -2.85. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Embracing Future Holdings (SGX:8YY), the current FCF Yield % is -2.85 as of Jul. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Embracing Future Holdings Ltd is engaged in technology development, technology transfer, marketing, sales, and distribution of biomedical technology, life, and medicine science-related products and services, and investment holding. The company's business segments are: Cancer, Infectious Diseases, E-sports, Advertising, and Corporate. The company generates the majority of its revenue from the E-sports segment, which involves identifying and assessing potential collaboration partners, technology, digital platforms, products, and services related to E-Sports. Its operations are spread across Singapore, Japan, China, Europe, Hong Kong, Thailand, Malaysia, and other countries.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SGX:8YY has been successfully added to your 
